The satiety adipokine Nesfatin-1/NUCB2 is expressed in human term trophoblast and placental mesenchymal stem cells and is increased during oxidative and ER stress — ASN Events

The satiety adipokine Nesfatin-1/NUCB2 is expressed in human term trophoblast and placental mesenchymal stem cells and is increased during oxidative and ER stress (#217)

Penny Jeffery 1 , Rebecca Pelekanos 2 , Rohan Lourie 1 3 , Kirsten Gerloff 1 , Lisa Chopin 4 , Inge Seim 4 , Nicholas Fisk 2 , Michael McGuckin 1
  1. Mater Medical Research Institute, Brisbane, Australia
  2. University of Queensland Centre for Clinical Research, Brisbane, Australia
  3. Department of Pathology, Mater Health Services, Brisbane, Australia
  4. Institute of Health and Biomedical Innovation, QUT, Brisbane, Australia

Nesfatin-1 is an 82 amino acid anorectic adipokine derived from the nucleobindin2 precursor protein (NUCB2). Via interaction with melanocortin 3/4 receptors in the hypothalamus, nesfatin-1 inhibits food intake and increases blood pressure in rodents. In humans nesfatin-1/NUCB2 is widely expressed, however, its expression in gestational tissues has not been previously reported. Here we demonstrate that nesfatin-1/NUCB2 protein is expressed in the highly-secretory syncytiotrophoblast of human term placenta and in the trophoblast cell lines JEG-3 and BeWo. Isolated mesenchymal stem cells from the chorionic membrane (CM-MSC) and chorionic villi (CV-MSC) also express NUCB2 at the mRNA level. Endoplasmic reticulum (ER) stress has recently been implicated in placental pathologies which can result in pre-eclampsia and intrauterine growth restriction. The NUCB2 promoter region contains cis-elements for transcriptional activation by ATF6, a transcription factor involved in the unfolded protein response. Using the chemical ER stressor tunicamycin and spliced XBP-1 as a marker of ER stress, we demonstrate that ER stress increases NUCB2 expression in JEG-3 and BeWo cells and in CM-MSC and CV-MSC. 24 hour treatment with non-cytotoxic doses of tunicamycin (0.9µg/ml) increases NUCB2 mRNA expression by 2.2 (+/-0.6) fold in the JEG-3 cell line and by 2.5 (+/-0.5) fold in the BeWo cell line. Both CM-MSC and CV-MSC were more sensitive to tunicamycin than were the choriocarcinoma cell lines and therefore a lower stressor dose was required. Tunicamycin (0.6µg/ml) - induced ER stress resulted in a 2.7 (+/-0.8) and 1.9 (+/-0.9) fold increase in NUCB2 transcription in CM-MSC and CV-MSC respectively. Collectively, these data indicate that NUCB2 is an ER-stress responsive gene expressed in term placenta and placental cell lines and MSC. Future work will investigate if nesfatin-1/NUCB2 is increased in tissues from pre-eclamptic pregnancies and other placental pathology where ER stress is evident.